A ribosomopathy reveals decoding defective ribosomes driving human dysmorphism.
Ribosomal protein (RP) gene mutations, mostly associated with inherited or acquired bone marrow failure, are believed to drive disease by slowing the rate of protein synthesis. Here de novo missense mutations in the RPS23 gene, which codes for uS12, are reported in two unrelated individuals with mic...
Main Authors: | Paolini, N, Attwood, M, Sondalle, S, Vieira, C, van Adrichem, A, di Summa, F, O'Donohue, M, Gleizes, P, Rachuri, S, Briggs, J, Fischer, R, Ratcliffe, P, Wlodarski, M, Houtkooper, R, von Lindern, M, Kuijpers, T, Dinman, J, Baserga, S, Cockman, M, MacInnes, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2017
|
Similar Items
-
Cancer Biogenesis in Ribosomopathies
by: Sergey O. Sulima, et al.
Published: (2019-03-01) -
Ribosomopathies: Mechanisms of Disease
by: Hani Nakhoul, et al.
Published: (2014-08-01) -
Ribosomopathies: Mechanisms of Disease
by: Hani Nakhoul, et al.
Published: (2014-01-01) -
Ribosomopathies: New Therapeutic Perspectives
by: Emilien Orgebin, et al.
Published: (2020-09-01) -
HMG-boxes, ribosomopathies and neurodegenerative disease
by: Tom Moss, et al.
Published: (2023-08-01)